IQOS and Your Lungs: What the Evidence Shows So Far

Heated tobacco puts a warm aerosol carrying nicotine, fine particles and thermal breakdown products into your airways every time you draw on it. It contains lower levels of several of the toxicants that make cigarette smoke lethal. Both of those sentences are true, and the honest position is that we do not yet know what the second one buys you over thirty years.

That uncertainty is not a technicality to hurry past. It is the answer.

What the reduced-exposure studies actually measured

The phrase “reduced exposure” gets repeated so often that it has started to sound like a health finding. It is a chemistry finding.

Laboratory analyses compare the aerosol from a heated stick with the smoke from a cigarette and count specific compounds. Because heated tobacco is held around 300 to 350°C rather than the 600 to 900°C of a burning tip, several signature combustion products come out substantially lower. Clinical switching studies then measure biomarkers of exposure in blood and urine, and those also drop when someone switches completely.

Two things are worth knowing about that body of work.

First, the distinction the regulator drew. In 2020 the US FDA authorised a claim that IQOS reduces exposure to certain harmful chemicals, and explicitly refused a claim of reduced harm or reduced disease risk, on the grounds that the evidence did not support one.

Second, what happened when independent researchers looked at the manufacturer’s own trial data. Reanalyses published in the peer-reviewed tobacco control literature reported that the large majority of biomarkers of potential harm, the ones meant to reflect biological effect rather than intake, did not differ significantly between people who switched and people who kept smoking.

Lower intake of a toxicant is a hypothesis about health. It is not a measurement of health.

What people actually report

Setting the laboratory aside, the pattern in user reports and in the clinical literature is fairly consistent.

Many people who switch completely from cigarettes describe less morning cough and less breathlessness within a few weeks. That is real, and it is what you would expect when carbon monoxide falls and tar production stops.

At the same time, throat and airway irritation is among the most commonly reported effects of heated tobacco itself, including in people who never had it as smokers. A dry, scratchy throat, a cough triggered by the first stick of the day, and a sensation of tightness after several sticks in a row all show up regularly.

There are also isolated published case reports, mostly from countries where heated tobacco use is widespread, describing acute lung problems in users. Case reports are not incidence rates and should not be read as one. They are the kind of early signal that later becomes either a footnote or a research programme, and right now nobody can tell you which.

The gap that matters most

Heated tobacco reached the market around 2014. Take that seriously for a moment.

What we know about cigarettes and lungs came from following millions of people for decades. Chronic obstructive pulmonary disease and lung cancer develop over twenty to fifty years of exposure. The first solid evidence linking smoking to lung cancer arrived roughly half a century after cigarettes became a mass-market product, and it took decades more for the size of the effect to be pinned down.

Nobody has followed a heated tobacco user for thirty years, because thirty years have not passed. That is why the World Health Organization treats heated tobacco products as tobacco products under the Framework Convention on Tobacco Control rather than as a resolved harm-reduction category, and why no regulator anywhere has authorised a reduced-risk claim.

There is one more thing the studies keep finding that is easy to skip over. A large share of heated tobacco users also smoke cigarettes at least sometimes. For a dual user, none of the switching research applies at all: it was conducted on people who switched completely, and the practical result of the device is often more total nicotine occasions per day rather than fewer.

When a cough needs a doctor

Most coughs are not emergencies, and some are worth an appointment rather than a search.

See a doctor for a cough lasting more than three weeks, a cough that brings up blood, breathlessness on ordinary activity that is new for you, chest pain, unexplained weight loss, or a persistent wheeze. Tell them you use heated tobacco and give the number of sticks a day. It is different clinical information from “I do not smoke”, and it changes what they consider.

What your lungs do after you stop

Faster than people expect, and it starts immediately.

Carbon monoxide clears within roughly 12 hours of the last stick. Nicotine is largely gone within about 72 hours. Over one to nine months, the cilia lining the airways regain function and start clearing mucus properly again, which is the phase where coughing and breathlessness noticeably improve (CDC). Some people cough more for a few weeks first, which is the clearance system switching back on rather than something going wrong.

Lung function lost to years of exposure does not come back. What stopping does is slow the accelerated decline back toward the ordinary age-related rate, which is why doing it at 35 is worth more than at 55, and doing it at 55 is still clearly worth doing.

Most people who stopped for good had tried before, often several times. That is the normal shape of it. The thing that usually separates the attempt that holds is having a real number instead of a rough impression.

So here is the two-minute version for today: count every stick you use and change nothing else. No reduction, no rules, just an accurate tally for three days.

Puff Counter exists for exactly that: one tap per stick, and each week’s ceiling set from your own average rather than a target someone else chose.

The long-term lung data on heated tobacco will arrive eventually. You do not have to be in the study.